346 related articles for article (PubMed ID: 26872051)
1. Light Fractionation Significantly Increases the Efficacy of Photodynamic Therapy Using BF-200 ALA in Normal Mouse Skin.
de Bruijn HS; Brooks S; van der Ploeg-van den Heuvel A; Ten Hagen TL; de Haas ER; Robinson DJ
PLoS One; 2016; 11(2):e0148850. PubMed ID: 26872051
[TBL] [Abstract][Full Text] [Related]
2. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
3. Fractionated illumination after topical application of 5-aminolevulinic acid on normal skin of hairless mice: the influence of the dark interval.
de Bruijn HS; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
J Photochem Photobiol B; 2006 Dec; 85(3):184-90. PubMed ID: 16945548
[TBL] [Abstract][Full Text] [Related]
4. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.
de Souza AL; Marra K; Gunn J; Samkoe KS; Kanick SC; Davis SC; Chapman MS; Maytin EV; Hasan T; Pogue BW
Br J Cancer; 2016 Sep; 115(7):805-13. PubMed ID: 27575852
[TBL] [Abstract][Full Text] [Related]
5. Photobleaching during and re-appearance after photodynamic therapy of topical ALA-induced fluorescence in UVB-treated mouse skin.
Van der Veen N; De Bruijn HS; Star WM
Int J Cancer; 1997 Jul; 72(1):110-8. PubMed ID: 9212231
[TBL] [Abstract][Full Text] [Related]
6. Light fractionation does not enhance the efficacy of methyl 5-aminolevulinate mediated photodynamic therapy in normal mouse skin.
de Bruijn HS; de Haas ER; Hebeda KM; van der Ploeg-van den Heuvel A; Sterenborg HJ; Neumann HA; Robinson DJ
Photochem Photobiol Sci; 2007 Dec; 6(12):1325-31. PubMed ID: 18046489
[TBL] [Abstract][Full Text] [Related]
7. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
van der Veen N; Hebeda KM; de Bruijn HS; Star WM
Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
[TBL] [Abstract][Full Text] [Related]
9. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.
de Bruijn HS; Meijers C; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
J Photochem Photobiol B; 2008 Aug; 92(2):91-7. PubMed ID: 18571933
[TBL] [Abstract][Full Text] [Related]
10. Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin.
Robinson DJ; de Bruijn HS; Star WM; Sterenborg HJ
Photochem Photobiol; 2003 Mar; 77(3):319-23. PubMed ID: 12685661
[TBL] [Abstract][Full Text] [Related]
11. Epidermal penetration and protoporphyrin IX formation of two different 5-aminolevulinic acid formulations in ex vivo human skin.
Schmitz L; Novak B; Hoeh AK; Luebbert H; Dirschka T
Photodiagnosis Photodyn Ther; 2016 Jun; 14():40-6. PubMed ID: 26607556
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence photobleaching of ALA and ALA-heptyl ester induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: a comparison of two light sources and different illumination schemes.
Pudroma X; Juzeniene A; Ma LW; Iani V; Moan J
J Environ Pathol Toxicol Oncol; 2011; 30(3):235-40. PubMed ID: 22126616
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825
[TBL] [Abstract][Full Text] [Related]
15. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses.
Fauteck JD; Ackermann G; Birkel M; Breuer M; Moor AC; Ebeling A; Ortland C
Arch Dermatol Res; 2008 Feb; 300(2):53-60. PubMed ID: 17960406
[TBL] [Abstract][Full Text] [Related]
17. A HCl/alcohol formulation increased 5-aminolevulinic acid skin distribution using an ex vivo full thickness porcine skin model.
Maisch T; Worlicek C; Babilas P; Landthaler M; Szeimies RM
Exp Dermatol; 2008 Oct; 17(10):813-20. PubMed ID: 18380780
[TBL] [Abstract][Full Text] [Related]
18. Intracutaneous ALA photodynamic therapy: dose-dependent targeting of skin structures.
Sakamoto FH; Doukas AG; Farinelli WA; Tannous Z; Su Y; Smith NA; Zurakowski D; Anderson RR
Lasers Surg Med; 2011 Sep; 43(7):621-31. PubMed ID: 22057490
[TBL] [Abstract][Full Text] [Related]
19. Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum.
van den Akker JT; Iani V; Star WM; Sterenborg HJ; Moan J
Photochem Photobiol; 2000 Nov; 72(5):681-9. PubMed ID: 11107855
[TBL] [Abstract][Full Text] [Related]
20. Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin.
Robinson DJ; de Bruijn HS; van der Veen N; Stringer MR; Brown SB; Star WM
Photochem Photobiol; 1999 Jan; 69(1):61-70. PubMed ID: 10063801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
